ORBIMED CAPITAL LLC
Insider CIK 1157524 · SRRA Director, 10% owner · CCXI 10% owner · ALEC Director, 10% owner · DBTX Director, 10% owner · SBTX Director, 10% owner · IMRA Director, 10% owner · PRLD Director, 10% owner · PMVP Director, 10% owner · ARQT Director, 10% owner · KNTE Director, 10% owner · FUSN Director · RPTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PRLD Prelude Therapeutics Inc | P Buy | 2026-04-21 | 2026-04-23 | 1,126,126 | $4.44 | $5.00M | 1,126,126 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2026-04-21 | 2026-04-23 | 1,689,189 | $4.44 | $7.50M | 11,808,945 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-26 | 2024-08-28 | 83,695 | $13.00 | $1.09M | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-23 | 2024-08-23 | 69,500 | $13.03 | $905.6K | 83,695 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-22 | 2024-08-23 | 391,482 | $12.94 | $5.07M | 153,195 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-21 | 2024-08-23 | 13,300 | $14.61 | $194.3K | 544,677 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | S Sale | 2024-08-21 | 2024-08-23 | 394,400 | $13.52 | $5.33M | 557,977 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 84,599 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 450,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,338 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 1,368,339 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer | 2024-04-03 | 2024-04-05 | 4,738,453 | — | $0 | 0 | SEC↗ |
| SPRY ARS Pharmaceuticals, Inc. | P Buy | 2023-08-29 | 2023-08-31 | 500,000 | $6.20 | $3.10M | 8,019,187 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2023-05-22 | 2023-05-24 | 869,565 | $5.75 | $5.00M | 10,119,756 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,512 | $2.82 | $1.38M | 1,368,339 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-05 | 2023-05-08 | 490,511 | $2.82 | $1.38M | 1,368,338 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 312,991 | $2.75 | $860.7K | 4,738,453 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-04 | 2023-05-08 | 83,459 | $2.75 | $229.5K | 877,827 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 220,610 | $2.67 | $589.0K | 4,425,462 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-02 | 2023-05-02 | 58,826 | $2.67 | $157.1K | 794,368 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,544 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 467,068 | $2.62 | $1.22M | 4,204,852 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-05-01 | 2023-05-02 | 124,545 | $2.62 | $326.3K | 735,542 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 228,754 | $2.55 | $583.3K | 3,737,784 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,997 | $2.55 | $155.5K | 610,997 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2023-04-28 | 2023-05-02 | 60,998 | $2.55 | $155.5K | 610,998 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-23 | 550,000 | — | $0 | 550,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award | 2023-02-17 | 2023-02-23 | 550,000 | — | $0 | 550,000 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 1,136,250 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 170,437 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer deriv | 2022-07-01 | 2022-07-01 | 170,437 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 226,704 | $55.00 | $12.47M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 226,704 | $55.00 | $12.47M | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | D To issuer | 2022-07-01 | 2022-07-01 | 1,511,362 | $55.00 | $83.12M | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-06-24 | 2022-06-28 | 306,027 | $21.31 | $6.52M | 3,534,537 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-06-24 | 2022-06-28 | 35,944 | $21.31 | $766.0K | 415,142 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-08 | 2022-04-08 | 102,800 | $20.71 | $2.13M | 451,086 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-08 | 2022-04-08 | 97,200 | $20.71 | $2.01M | 3,840,564 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-07 | 2022-04-08 | 177,196 | $20.66 | $3.66M | 553,886 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-07 | 2022-04-08 | 167,800 | $20.66 | $3.47M | 3,937,764 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-06 | 2022-04-08 | 171,204 | $20.69 | $3.54M | 731,082 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | S Sale | 2022-04-06 | 2022-04-08 | 162,000 | $20.69 | $3.35M | 4,105,564 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2022-03-31 | 2022-03-31 | 34,500 | $21.17 | $730.4K | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2022-03-30 | 2022-03-31 | 75,000 | $22.39 | $1.68M | 34,500 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | S Sale | 2022-03-29 | 2022-03-31 | 365,000 | $21.52 | $7.85M | 109,500 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-15 | 2022-02-15 | 9,000 | $9.96 | $89.6K | 3,509,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-14 | 2022-02-15 | 10,000 | $9.89 | $98.9K | 3,500,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-14 | 2022-02-15 | 20,700 | $9.98 | $206.6K | 3,490,030 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2022-02-11 | 2022-02-15 | 156,000 | $10.22 | $1.59M | 3,469,330 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 56,244 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 374,962 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise deriv | 2022-01-26 | 2022-01-28 | 56,244 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 56,244 | $13.20 | $742.4K | 226,704 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 374,962 | $13.20 | $4.95M | 1,511,362 | SEC↗ |
| SRRA Sierra Oncology, Inc. | X Exercise | 2022-01-26 | 2022-01-28 | 56,244 | $13.20 | $742.4K | 226,704 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-07 | 2021-09-08 | 26 | $33.93 | $882 | 96,190 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-07 | 2021-09-08 | 861 | $33.93 | $29.2K | 3,177,041 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-03 | 2021-09-08 | 6,985 | $34.00 | $237.5K | 3,177,902 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-03 | 2021-09-08 | 212 | $34.00 | $7.2K | 96,216 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-02 | 2021-09-02 | 483 | $34.24 | $16.5K | 96,428 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-02 | 2021-09-02 | 15,941 | $34.24 | $545.8K | 3,184,887 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-01 | 2021-09-02 | 382 | $33.98 | $13.0K | 96,911 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-09-01 | 2021-09-02 | 12,586 | $33.98 | $427.7K | 3,200,828 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-31 | 2021-09-02 | 249 | $33.94 | $8.5K | 97,293 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-31 | 2021-09-02 | 8,223 | $33.94 | $279.1K | 3,213,414 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-30 | 2021-08-30 | 197 | $33.92 | $6.7K | 97,542 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-30 | 2021-08-30 | 6,500 | $33.92 | $220.5K | 3,221,637 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-27 | 2021-08-30 | 209 | $33.94 | $7.1K | 97,739 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-27 | 2021-08-30 | 6,884 | $33.94 | $233.6K | 3,228,137 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-26 | 2021-08-30 | 126 | $34.52 | $4.3K | 97,948 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-26 | 2021-08-30 | 4,157 | $34.52 | $143.5K | 3,235,021 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-25 | 2021-08-25 | 208 | $34.34 | $7.1K | 98,074 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-25 | 2021-08-25 | 6,874 | $34.34 | $236.1K | 3,239,178 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-24 | 2021-08-25 | 119 | $34.07 | $4.1K | 98,282 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-24 | 2021-08-25 | 3,920 | $34.07 | $133.6K | 3,246,052 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-23 | 2021-08-25 | 209 | $34.06 | $7.1K | 98,401 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-23 | 2021-08-25 | 6,885 | $34.06 | $234.5K | 3,249,972 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-18 | 2021-08-19 | 2,852 | $33.99 | $96.9K | 3,256,857 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-18 | 2021-08-19 | 78 | $33.99 | $2.7K | 98,610 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-17 | 2021-08-19 | 512 | $34.12 | $17.5K | 98,688 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-08-17 | 2021-08-19 | 16,886 | $34.12 | $576.2K | 3,259,439 | SEC↗ |
| IMRA IMARA Inc. | P Buy | 2021-07-16 | 2021-07-16 | 1,666,666 | $6.00 | $10.00M | 1,666,666 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 14,480,162 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,737,619 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion deriv | 2021-02-17 | 2021-02-19 | 1,158,412 | — | $0 | 0 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 2,732,106 | — | $0 | 2,732,106 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | P Buy | 2021-02-17 | 2021-02-19 | 555,566 | $18.00 | $10.00M | 883,418 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 327,852 | — | $0 | 327,852 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | C Conversion | 2021-02-17 | 2021-02-19 | 218,568 | — | $0 | 218,568 | SEC↗ |
| DBTX Decibel Therapeutics, Inc. | P Buy | 2021-02-17 | 2021-02-19 | 1,111,100 | $18.00 | $20.00M | 3,843,206 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy deriv | 2021-01-11 | 2021-01-12 | 41,700 | $60.00 | $2.50M | 5,596,886 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 12,857,142 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 3,918,279 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion deriv | 2020-12-08 | 2020-12-08 | 9,259,259 | — | $0 | 0 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 2,493,741 | — | $0 | 6,463,901 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 1,055,287 | — | $0 | 7,519,188 | SEC↗ |
| SBTX Silverback Therapeutics, I | P Buy | 2020-12-08 | 2020-12-08 | 952,377 | $21.00 | $20.00M | 952,377 | SEC↗ |
| SBTX Silverback Therapeutics, I | C Conversion | 2020-12-08 | 2020-12-08 | 3,462,737 | — | $0 | 3,970,160 | SEC↗ |
| SBTX Silverback Therapeutics, I | P Buy | 2020-12-08 | 2020-12-08 | 238,100 | $21.00 | $5.00M | 507,423 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 118,398 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 24,555 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 9,461 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 50,501 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 2,651,042 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion deriv | 2020-12-07 | 2020-12-09 | 243,494 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 9,461 | — | $0 | 59,962 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 24,637 | — | $0 | 84,599 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 50,501 | — | $0 | 50,501 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 118,794 | — | $0 | 3,313,330 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 2,651,042 | — | $0 | 3,194,536 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | C Conversion | 2020-12-07 | 2020-12-09 | 243,494 | — | $0 | 543,494 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2020-12-02 | 2020-12-04 | 450,000 | $20.00 | $9.00M | 450,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | P Buy | 2020-12-02 | 2020-12-04 | 300,000 | $20.00 | $6.00M | 300,000 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-10-02 | 2020-10-06 | 200,000 | $25.00 | $5.00M | 4,267,564 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-10-02 | 2020-10-06 | 296,000 | $25.00 | $7.40M | 902,286 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 114,039 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 380,133 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 518,191 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 1,076,891 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion deriv | 2020-09-29 | 2020-09-29 | 4,025,076 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 5,555,186 | — | $0 | 5,555,186 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 3,294,743 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 2,196,494 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 4,418,186 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 2,945,458 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 619,850 | — | $0 | 0 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion deriv | 2020-09-29 | 2020-09-29 | 413,234 | — | $0 | 0 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 380,133 | — | $0 | 6,475,291 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 518,191 | — | $0 | 6,095,158 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 4,025,076 | — | $0 | 4,500,076 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 114,039 | — | $0 | 114,039 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | C Conversion | 2020-09-29 | 2020-09-29 | 1,076,891 | — | $0 | 5,576,967 | SEC↗ |
| PRLD Prelude Therapeutics Inc | C Conversion | 2020-09-29 | 2020-09-29 | 8,332,779 | — | $0 | 9,250,191 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | P Buy | 2020-09-25 | 2020-09-29 | 475,000 | $18.00 | $8.55M | 475,000 | SEC↗ |
| PMVP PMV Pharmaceuticals, Inc. | P Buy | 2020-09-25 | 2020-09-29 | 475,000 | $18.00 | $8.55M | 475,000 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2020-09-25 | 2020-09-29 | 526,300 | $19.00 | $10.00M | 526,300 | SEC↗ |
| PRLD Prelude Therapeutics Inc | P Buy | 2020-09-25 | 2020-09-29 | 710,500 | $19.00 | $13.50M | 917,412 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | C Conversion deriv | 2020-06-30 | 2020-07-02 | 11,878,051 | — | $0 | 0 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | P Buy | 2020-06-30 | 2020-07-02 | 192,100 | $17.00 | $3.27M | 192,100 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | P Buy | 2020-06-30 | 2020-07-02 | 705,900 | $17.00 | $12.00M | 2,930,670 | SEC↗ |
| FUSN Fusion Pharmaceuticals Inc | C Conversion | 2020-06-30 | 2020-07-02 | 2,224,770 | — | $0 | 2,224,770 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 2,601,325 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 2,601,325 | — | $0 | 2,601,325 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2020-06-23 | 2020-06-25 | 675,000 | $20.00 | $13.50M | 3,276,325 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2020-06-23 | 2020-06-25 | 99,200 | $20.00 | $1.98M | 99,200 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 38,808 | $26.00 | $1.01M | 0 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 445,086 | $26.00 | $11.57M | 2,113,877 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-03-02 | 2020-03-04 | 1,390,309 | $26.00 | $36.15M | 6,602,467 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-04 | 859,573 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-04 | 429,786 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion deriv | 2020-02-04 | 2020-02-04 | 2,825,603 | — | $0 | 0 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-04 | 859,573 | — | $0 | 4,067,564 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-04 | 2,825,603 | — | $0 | 3,207,991 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | C Conversion | 2020-02-04 | 2020-02-04 | 429,786 | — | $0 | 606,286 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-02-03 | 2020-02-04 | 176,500 | $17.00 | $3.00M | 176,500 | SEC↗ |
| ARQT Arcutis Biotherapeutics, I | P Buy | 2020-02-03 | 2020-02-04 | 382,388 | $17.00 | $6.50M | 382,388 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion deriv | 2020-01-29 | 2020-01-31 | 19,500 | — | $0 | 0 | SEC↗ |
| SRRA Sierra Oncology, Inc. | C Conversion | 2020-01-29 | 2020-01-31 | 1,477,320 | — | $0 | 1,477,320 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-01-09 | 2020-01-13 | 286,787 | $19.50 | $5.59M | 7,992,776 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-01-09 | 2020-01-13 | 91,818 | $19.50 | $1.79M | 2,558,963 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2020-01-09 | 2020-01-13 | 1,392 | $19.50 | $27.1K | 38,808 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-26 | 2019-12-26 | 2,325 | $18.60 | $43.2K | 2,650,781 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-26 | 2019-12-26 | 7,275 | $18.60 | $135.3K | 8,279,563 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-26 | 2019-12-26 | 1,200 | $18.60 | $22.3K | 40,200 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-24 | 2019-12-26 | 8,000 | $19.59 | $156.7K | 41,400 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-24 | 2019-12-26 | 15,476 | $19.59 | $303.2K | 2,653,106 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-24 | 2019-12-26 | 48,324 | $19.59 | $946.7K | 8,286,838 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-23 | 2019-12-26 | 20,350 | $19.82 | $403.3K | 2,668,582 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-23 | 2019-12-26 | 10,400 | $19.82 | $206.1K | 49,400 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-23 | 2019-12-26 | 63,535 | $19.82 | $1.26M | 8,335,162 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-20 | 2019-12-26 | 230,721 | $19.66 | $4.54M | 8,398,697 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-20 | 2019-12-26 | 73,879 | $19.66 | $1.45M | 2,688,932 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-20 | 2019-12-26 | 37,900 | $19.66 | $745.1K | 59,800 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-17 | 2019-12-19 | 205,793 | $18.52 | $3.81M | 2,762,811 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-17 | 2019-12-19 | 642,807 | $18.52 | $11.90M | 8,629,418 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-12-17 | 2019-12-19 | 105,500 | $18.52 | $1.95M | 97,700 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-08-07 | 2019-08-09 | 492,364 | $17.90 | $8.81M | 9,272,225 | SEC↗ |
| ALEC Alector, Inc. | S Sale | 2019-08-07 | 2019-08-09 | 157,636 | $17.90 | $2.82M | 2,968,604 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 405,925 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 94,075 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 992,437 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 2,029,626 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 470,374 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 2,280,479 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 528,510 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 1,012,282 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 234,601 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 266,437 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 85,295 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | C Conversion deriv | 2019-02-11 | 2019-02-11 | 4,282,288 | — | $0 | 0 | SEC↗ |
| ALEC Alector, Inc. | P Buy | 2019-02-11 | 2019-02-11 | 157,939 | $19.00 | $3.00M | 10,434,976 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 94,075 | — | $0 | 94,075 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 470,374 | — | $0 | 1,556,886 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 266,437 | — | $0 | 10,277,037 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 1,012,282 | — | $0 | 10,010,600 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 2,280,479 | — | $0 | 8,998,318 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 2,029,626 | — | $0 | 6,717,839 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 4,282,288 | — | $0 | 4,688,213 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 405,925 | — | $0 | 405,925 | SEC↗ |
| ALEC Alector, Inc. | P Buy | 2019-02-11 | 2019-02-11 | 203,200 | $19.00 | $3.86M | 203,200 | SEC↗ |
| ALEC Alector, Inc. | P Buy | 2019-02-11 | 2019-02-11 | 50,561 | $19.00 | $960.7K | 2,455,853 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 85,295 | — | $0 | 2,405,292 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 234,601 | — | $0 | 2,319,997 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 528,510 | — | $0 | 2,085,396 | SEC↗ |
| ALEC Alector, Inc. | C Conversion | 2019-02-11 | 2019-02-11 | 992,437 | — | $0 | 1,086,512 | SEC↗ |
| CCXI ChemoCentryx, Inc. | C Conversion deriv | 2012-02-13 | 2012-02-15 | 1,574,345 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | C Conversion deriv | 2012-02-13 | 2012-02-15 | 514,354 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | C Conversion deriv | 2012-02-13 | 2012-02-15 | 3,888,423 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | C Conversion deriv | 2012-02-13 | 2012-02-15 | 242,674 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | C Conversion deriv | 2012-02-13 | 2012-02-15 | 10,706 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | C Conversion deriv | 2012-02-13 | 2012-02-15 | 78,928 | — | $0 | 0 | SEC↗ |
| CCXI ChemoCentryx, Inc. | C Conversion | 2012-02-13 | 2012-02-15 | 908,509 | — | $0 | 908,509 | SEC↗ |
| CCXI ChemoCentryx, Inc. | C Conversion | 2012-02-13 | 2012-02-15 | 44,817 | — | $0 | 44,817 | SEC↗ |
| CCXI ChemoCentryx, Inc. | C Conversion | 2012-02-13 | 2012-02-15 | 2,201,388 | — | $0 | 2,201,388 | SEC↗ |